Outlook: Zeneca has been slow to change
Tuesday 02 December 1997
However, as Zeneca yesterday defended itself against accusations that it has failed to respond quickly enough to market changes and has let its drug pipeline run dry, it is Zeneca, not ICI, which looks unable to throw off the shackles of its old corporate identity. While ICI, under ex-Unilever man Charles Miller Smith, has been busy reinventing itself, swapping at record speed commodities business for high-margin speciality chemicals, Zeneca looks like it has only just caught the boat on many market developments - biotechnology alliances, genomics, for example - which have turned its more aggressive competitors Glaxo Wellcome and SmithKline Beecham into world forces in the drug industry.
Not surprisingly Zeneca has been a much better investment than ICI. Over the past four years, shares in Zeneca have outperformed the market by almost 70 per cent, compared to a dismal 21 per cent underperformance from ICI. However the chemicals and drugs sectors naturally attract different share price ratings. Moreover, much of Zeneca's share price growth has been driven by bid speculation.
There aren't many medium-sized drug companies left to buy and in an industry where global consolidation makes sense, Zeneca has been a natural bid target. Unfortunately, potential buyers look in short supply. Roche has splashed much of its cash on other acquisitions and Glaxo would have to think hard about another hostile bid, given the disruption that integrating Wellcome caused. Without a bidder, Zeneca looks exposed. Though it tried hard yesterday to point out how many new products it had coming on line, most of what it has to offer are new versions of existing drugs rather than a full pipeline of late-stage products ready to launch.
Zeneca's main problem is management in general and the congenial Sir David Barnes in particular. Those who know the company talk of an English gentleman's club atmosphere where never a harsh word is raised. In the absence of a bidder, things plainly need to change.
- 1 Nigel Farage: Me vs Russell Brand on Question Time – he's got the chest hair but where are his ideas?
- 2 Harry Potter fans can apply to the Hogwarts-inspired College of Wizardry
- 3 Jessica Chambers: 19-year-old woman 'doused with lighter fluid and burned alive' in the US
- 4 Russell Brand calls Nigel Farage 'poundshop Enoch Powell' in BBC Question Time debate
- 5 Orange Wednesdays are no more
Weather bomb in pictures: Storms cuts power for tens of thousands – and snow is on the way
Jessica Chambers: 19-year-old woman 'doused with lighter fluid and burned alive' in the US
Russell Brand calls Nigel Farage 'poundshop Enoch Powell' in BBC Question Time debate
Russell Brand was rendered speechless on Question Time by this man
Fury at Airbus after it hints the super-jumbo may be mothballed
Disgruntled RBS worker writes hilarious open letter to Russell Brand after anti-capitalist publicity stunt leaves him hungry
Nigel Farage defends Kerry Smith 'ch***y' comment: 'If you are going for a Chinese, what do you say you’re going for?'
Nigel Farage's approval rating hits 'record low' as popularity suffers in wake of Ukip sex scandal
Pakistan school attack live: Taliban kill at least 132 children in 'horrifying' massacre
Sony hack: Angelina Jolie branded 'seriously out of her mind' in further embarrassing leaked email saga
Panic Saturday: 13 million Britons spend £1.2bn – while 13 million others across the country live in poverty unable to afford food
iJobs Money & Business
£20000 - £25000 per annum + OTE £40,000 + Car + Pension: SThree: SThree are a ...
£20000 - £25000 per annum + OTE £35K: SThree: We consistently strive to be the...
£20000 - £25000 per annum + OTE £35000: SThree: SThree are a global FTSE 250 b...
£20000 - £25000 per annum + OTE £35K - £45K: SThree: SThree Group have been we...